Literature DB >> 29608140

Strategies targeting cellular senescence.

Yossi Ovadya, Valery Krizhanovsky.   

Abstract

Cellular senescence is a physiological phenomenon that has both beneficial and detrimental consequences. Senescence limits tumorigenesis and tissue damage throughout the lifetime. However, at the late stages of life, senescent cells increasingly accumulate in tissues and might also contribute to the development of various age-related pathologies. Recent studies have revealed the molecular pathways that preserve the viability of senescent cells and the ones regulating their immune surveillance. These studies provide essential initial insights for the development of novel therapeutic strategies for targeting senescent cells. At the same time they stress the need to understand the limitations of the existing strategies, their efficacy and safety, and the possible deleterious consequences of senescent cell elimination. Here we discuss the existing strategies for targeting senescent cells and upcoming challenges in translating these strategies into safe and efficient therapies. Successful translation of these strategies could have implications for treating a variety of diseases at old age and could potentially reshape our view of health management during aging.

Mesh:

Year:  2018        PMID: 29608140      PMCID: PMC5873866          DOI: 10.1172/JCI95149

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  105 in total

1.  MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.

Authors:  Remi-Martin Laberge; Yu Sun; Arturo V Orjalo; Christopher K Patil; Adam Freund; Lili Zhou; Samuel C Curran; Albert R Davalos; Kathleen A Wilson-Edell; Su Liu; Chandani Limbad; Marco Demaria; Patrick Li; Gene B Hubbard; Yuji Ikeno; Martin Javors; Pierre-Yves Desprez; Christopher C Benz; Pankaj Kapahi; Peter S Nelson; Judith Campisi
Journal:  Nat Cell Biol       Date:  2015-07-06       Impact factor: 28.824

2.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours.

Authors:  Tilman Oltersdorf; Steven W Elmore; Alexander R Shoemaker; Robert C Armstrong; David J Augeri; Barbara A Belli; Milan Bruncko; Thomas L Deckwerth; Jurgen Dinges; Philip J Hajduk; Mary K Joseph; Shinichi Kitada; Stanley J Korsmeyer; Aaron R Kunzer; Anthony Letai; Chi Li; Michael J Mitten; David G Nettesheim; ShiChung Ng; Paul M Nimmer; Jacqueline M O'Connor; Anatol Oleksijew; Andrew M Petros; John C Reed; Wang Shen; Stephen K Tahir; Craig B Thompson; Kevin J Tomaselli; Baole Wang; Michael D Wendt; Haichao Zhang; Stephen W Fesik; Saul H Rosenberg
Journal:  Nature       Date:  2005-05-15       Impact factor: 49.962

3.  Senescent intimal foam cells are deleterious at all stages of atherosclerosis.

Authors:  Bennett G Childs; Darren J Baker; Tobias Wijshake; Cheryl A Conover; Judith Campisi; Jan M van Deursen
Journal:  Science       Date:  2016-10-27       Impact factor: 47.728

4.  Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment.

Authors:  Ok Hee Jeon; Chaekyu Kim; Remi-Martin Laberge; Marco Demaria; Sona Rathod; Alain P Vasserot; Jae Wook Chung; Do Hun Kim; Yan Poon; Nathaniel David; Darren J Baker; Jan M van Deursen; Judith Campisi; Jennifer H Elisseeff
Journal:  Nat Med       Date:  2017-04-24       Impact factor: 53.440

5.  Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo.

Authors:  Florence Debacq-Chainiaux; Jorge D Erusalimsky; Judith Campisi; Olivier Toussaint
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

6.  Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Authors:  Stephan A Grupp; Michael Kalos; David Barrett; Richard Aplenc; David L Porter; Susan R Rheingold; David T Teachey; Anne Chew; Bernd Hauck; J Fraser Wright; Michael C Milone; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2013-03-25       Impact factor: 91.245

7.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).

Authors:  Utz Herbig; Wendy A Jobling; Benjamin P C Chen; David J Chen; John M Sedivy
Journal:  Mol Cell       Date:  2004-05-21       Impact factor: 17.970

Review 8.  Senescent cells: SASPected drivers of age-related pathologies.

Authors:  Yossi Ovadya; Valery Krizhanovsky
Journal:  Biogerontology       Date:  2014-09-13       Impact factor: 4.277

9.  Discovery of piperlongumine as a potential novel lead for the development of senolytic agents.

Authors:  Yingying Wang; Jianhui Chang; Xingui Liu; Xuan Zhang; Suping Zhang; Xin Zhang; Daohong Zhou; Guangrong Zheng
Journal:  Aging (Albany NY)       Date:  2016-11-19       Impact factor: 5.682

Review 10.  ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.

Authors:  Shundong Cang; Chaitanya Iragavarapu; John Savooji; Yongping Song; Delong Liu
Journal:  J Hematol Oncol       Date:  2015-11-20       Impact factor: 17.388

View more
  58 in total

1.  Hsp90 inhibitors as senolytic drugs to extend healthy aging.

Authors:  Heike Fuhrmann-Stroissnigg; Laura J Niedernhofer; Paul D Robbins
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

2.  T cells engineered to target senescence.

Authors:  Verena Wagner; Jesús Gil
Journal:  Nature       Date:  2020-07       Impact factor: 49.962

3.  Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.

Authors:  Denise P Muñoz; Steven M Yannone; Anneleen Daemen; Yu Sun; Funda Vakar-Lopez; Misako Kawahara; Adam M Freund; Francis Rodier; Jennifer D Wu; Pierre-Yves Desprez; David H Raulet; Peter S Nelson; Laura J van 't Veer; Judith Campisi; Jean-Philippe Coppé
Journal:  JCI Insight       Date:  2019-06-11

Review 4.  New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease.

Authors:  Xinghui Sun; Edward N Harris
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

Review 5.  Cellular senescence in ageing: from mechanisms to therapeutic opportunities.

Authors:  Raffaella Di Micco; Valery Krizhanovsky; Darren Baker; Fabrizio d'Adda di Fagagna
Journal:  Nat Rev Mol Cell Biol       Date:  2020-12-16       Impact factor: 94.444

Review 6.  Cellular senescence and radiation-induced pulmonary fibrosis.

Authors:  Yonghan He; Dinesh Thummuri; Guangrong Zheng; Paul Okunieff; Deborah E Citrin; Zeljko Vujaskovic; Daohong Zhou
Journal:  Transl Res       Date:  2019-03-27       Impact factor: 7.012

7.  Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL.

Authors:  Xuan Zhang; Dinesh Thummuri; Yonghan He; Xingui Liu; Peiyi Zhang; Daohong Zhou; Guangrong Zheng
Journal:  Chem Commun (Camb)       Date:  2019-12-05       Impact factor: 6.222

8.  Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.

Authors:  Miriam S Hohmann; David M Habiel; Ana L Coelho; Waldiceu A Verri; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

Review 9.  Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.

Authors:  Boris Hinz; David Lagares
Journal:  Nat Rev Rheumatol       Date:  2019-12-02       Impact factor: 20.543

Review 10.  Small-molecule drug repurposing to target DNA damage repair and response pathways.

Authors:  Jacqueline A Brinkman; Yue Liu; Stephen J Kron
Journal:  Semin Cancer Biol       Date:  2020-02-27       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.